CYP46A1 T/C polymorphism associated with the APOE ε4 allele increases the risk of Alzheimer's disease
- PMID: 23070465
- DOI: 10.1007/s00415-012-6690-4
CYP46A1 T/C polymorphism associated with the APOE ε4 allele increases the risk of Alzheimer's disease
Abstract
Studies of the relationship between Alzheimer's disease (AD) and single nucleotide polymorphism (SNP) T/C in intron 2 of the cholesterol-24S-hydroxylase gene (CYP46A1) have reported inconsistent results. To confirm the association between the CYP46A1 T/C polymorphism and AD risk, a meta-analysis containing 4,875 AD cases and 4,874 controls from 21 case-control studies was performed. There were 16 studies involving Europeans, four studies with Asians and one study with Africans. The combined results of overall analysis showed that the CYP46A1 T/C polymorphism increased the risk of AD significantly in recessive model [CC versus CT + TT, odds ratio (OR) = 1.20, 95 % confidence interval (CI) = 1.04-1.38, p = 0.01]. On subgroup analysis by ethnicity, similarly significant differences in recessive model were also found in Europeans. Another analysis of the synergistic effect of the CYP46A1 T/C polymorphism and the ε4 allele of the apolipoprotein E gene (APOE ε4) was performed in eight studies with available stratified information. The results revealed that the presence of APOE ε4 allele could strengthen the effect of CC genotype on AD risk, and the reverse was also true. In conclusion, our meta-analysis has successfully proved that CC genotype of the CYP46A1 T/C polymorphism could increase the risk of AD, and this effect would be weakened in APOE ε4 non-carriers and strengthened in APOE ε4 carriers.
Similar articles
-
Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease.Dement Geriatr Cogn Disord. 2006;21(2):81-7. doi: 10.1159/000090215. Epub 2005 Dec 9. Dement Geriatr Cogn Disord. 2006. PMID: 16340204
-
CYP46A1 intron-2T/C polymorphism and Alzheimer's disease: an updated meta-analysis of 16 studies including 3,960 cases and 3,828 controls.Neurosci Lett. 2013 Aug 9;549:18-23. doi: 10.1016/j.neulet.2013.06.011. Epub 2013 Jun 17. Neurosci Lett. 2013. PMID: 23792195
-
Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.Int J Immunogenet. 2020 Oct;47(5):397-405. doi: 10.1111/iji.12489. Epub 2020 Apr 24. Int J Immunogenet. 2020. PMID: 32333488
-
Association between Apolipoprotein E Gene Polymorphism and Alzheimer's Disease in an Iranian Population: A Meta-Analysis.J Mol Neurosci. 2019 Dec;69(4):557-562. doi: 10.1007/s12031-019-01381-1. Epub 2019 Aug 23. J Mol Neurosci. 2019. PMID: 31444704 Review.
-
Interleukin-1A -889C/T polymorphism and risk of Alzheimer's disease: a meta-analysis based on 32 case-control studies.J Neurol. 2012 Aug;259(8):1519-29. doi: 10.1007/s00415-011-6381-6. Epub 2012 Jan 11. J Neurol. 2012. PMID: 22234841 Review.
Cited by
-
Increased Plasma Level of 24S-Hydroxycholesterol and Polymorphism of CYP46A1 SNP (rs754203) Are Associated With Mild Cognitive Impairment in Patients With Type 2 Diabetes.Front Aging Neurosci. 2021 May 13;13:619916. doi: 10.3389/fnagi.2021.619916. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34054500 Free PMC article.
-
ABCA1-Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease.J Am Heart Assoc. 2016 Feb 12;5(2):e002886. doi: 10.1161/JAHA.115.002886. J Am Heart Assoc. 2016. PMID: 26873692 Free PMC article.
-
CYP46A1 and the APOEε4 Allele Polymorphisms Correlate with the Risk of Alzheimer's Disease.Mol Neurobiol. 2018 Oct;55(10):8179-8187. doi: 10.1007/s12035-018-0952-9. Epub 2018 Mar 7. Mol Neurobiol. 2018. PMID: 29516283
-
Controlling for confounding factors and revealing their interactions in genetic association meta-analyses: a computing method and application for stratification analyses.Oncotarget. 2018 Jan 29;9(15):12125-12136. doi: 10.18632/oncotarget.24335. eCollection 2018 Feb 23. Oncotarget. 2018. PMID: 29552297 Free PMC article.
-
Neurological update: dementia.J Neurol. 2014 Mar;261(3):635-9. doi: 10.1007/s00415-014-7249-3. Epub 2014 Feb 6. J Neurol. 2014. PMID: 24500494 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous